Scarica l'app Stockscreener
0.3642
6.38%
-0.0248
Precedente Chiudi:
$0.389
Aprire:
$0.3909
Volume 24 ore:
280.17K
Relative Volume:
0.41
Capitalizzazione di mercato:
$4.16M
Reddito:
-
Utile/perdita netta:
$-16.72M
Rapporto P/E:
-0.1194
EPS:
-3.0493
Flusso di cassa netto:
$-12.29M
1 W Prestazione:
-6.38%
1M Prestazione:
+15.58%
6M Prestazione:
-42.26%
1 anno Prestazione:
-69.65%
Intervallo 1D:
$0.3642
$0.3909
Intervallo di 1 settimana:
$0.3642
$0.406
Portata 52W:
$0.2002
$2.6399
Autonomix Medical Inc Stock (AMIX) Company Profile
Nome
Autonomix Medical Inc
Settore
Industria
Telefono
832-277-7816
Indirizzo
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
0.3642 | 4.16M | 0 | -16.72M | -12.29M | -3.0493 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Autonomix Medical Inc Borsa (AMIX) Ultime notizie
Autonomix Medical announces 1-for-21 reverse stock split - MSN
Autonomix Medical announces 1-for-21 reverse stock split By Investing.com - Investing.com Australia
Autonomix’s shares will be cut 21-for-1 on June 24 - Stock Titan
Autonomix Medical Inc (AMIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Autonomix Medical Inc (AMIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Autonomix Medical Inc (AMIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix Medical Inc (AMIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Autonomix Medical Inc (AMIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Autonomix Medical Inc (AMIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
Autonomix Medical Inc (AMIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
[10-K/A] Autonomix Medical, Inc. Amends Annual Report - Stock Titan
AMIX Q1 2026 Earnings: Narrower-than-expected loss fails to lift sharesEarnings Growth Analysis - newsline.com
AMIX Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineHealthcare Earnings Report - newsline.com
Autonomix Medical, Inc. Financial Disclosures & SEC Filings - TradingView
AMIX Q1 2026 Earnings: Narrower-than-Expected Loss Driven by Disciplined Cost ManagementQuarterly Profit Report - newsline.com
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology - The Globe and Mail
Autonomix Medical Announces Release of New CEO Corner - GlobeNewswire
Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why - MSN
Autonomix Medical (AMIX) Faces Continued Pressure Near $0.40 Support LevelDelta Hedging - newsline.com
Autonomix Medical executive discusses cancer pain treatment data By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. (AMIX) Latest Stock News & Headlines - Yahoo Finance
Autonomix Medical executive discusses cancer pain treatment data - Investing.com
Autonomix Medical Highlights Advances in Visceral Cancer Pain Treatment and Pancreatic Cancer Research in Investor Segment - Quiver Quantitative
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine - GlobeNewswire
Maxim Group Maintains Autonomix Medical(AMIX.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Autonomix Medical (AMIX) Declines 5.78% as Stock Tests Key Support at $0.37Mid Cap Momentum - newsline.com
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: EPS Surprise Delivers Narrower Loss, but Revenue Void Weighs on SharesNet Income Trends - lwvtexas.org
Autonomix Medical, Inc.: Advancing Precision Neuro-Ablation for Pancreatic Cancer Pain with Innovative Sensing Technology and De Novo FDA Pathway 39 - Minichart
Autonomix Medical FY 2026: Revenue $0 Net loss $16.7M, EPS $(2.32) — 10-K Summary - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Autonomix Medical (NASDAQ: AMIX) outlines novel nerve device plans amid going concern risk - Stock Titan
Autonomix Medical, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Autonomix Medical (AMIX) Holds Steady Near Support as Traders Eye Resistance BreakoutLate Stage Breakouts - The Legal Advocate
Autonomix Medical Inc. (AMIX) Edges Higher as Key Support Level HoldsSector Leader Stocks - Newser
Autonomix (AMIX) Jumps +8.71% on Strong Momentum 2026-05-20Ichimoku Kumo Twist - Newser
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation - marketscreener.com
Autonomix Medical, Inc. Granted U.S. Patent for - GlobeNewswire
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation - Sahm
Why Is Autonomix Medical, Inc. Common Stock (AMIX) Stock Down Today? - Meyka
New Autonomix patent aims for real-time feedback in nerve procedures - Stock Titan
Autonomix Medical announces abstract acceptances at EuroPCR 2026 showcasing long-term data in pancreatic cancer pain mitigation - marketscreener.com
Autonomix Medical Announces Abstract Acceptances At Europcr 2026 Showcasing Long-Term Data In Pancreatic Cancer Pain Mitigation - TradingView
Autonomix Medical to present new pancreatic cancer pain relief data at EuroPCR 2026 in Paris - Pluang
Autonomix Medical Announces Abstract Acceptances at EuroPCR - GlobeNewswire
TradingKey - TradingKey
AMIX Stock Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
AMIX: Autonomix Medical, Inc.Interactive Chart - Zacks Investment Research
Number of shareholders of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
How Autonomix (AMIX) stacks up against analyst expectations (Flirts with Support) 2026-05-08Social Buzz Stocks - Newser
Autonomix Medical Inc Azioni (AMIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):